Lagatar24 Desk
New Delhi: The Directorate General of Health Services (DGHS) has reassured the public about the spread of Human Metapneumovirus (HMPV) in China, urging people not to panic. Dr. Atul Goyal, a senior official at DGHS, emphasized that HMPV is similar to other respiratory viruses, typically causing common cold symptoms and flu-like conditions in vulnerable groups such as the elderly and young children.
“There is no specific antiviral treatment for HMPV, so prevention remains the key to controlling its spread,” Dr. Goyal said while addressing the media today. He recommended standard precautions to mitigate the risk of respiratory infections and assured that hospitals are prepared for the seasonal increase in respiratory illnesses typically seen during winter.
Key Highlights from Dr. Goyal’s Address:
•HMPV Characteristics: The virus is akin to other respiratory pathogens causing mild symptoms in most cases. Severe symptoms are rare and occur in high-risk groups.
•No Unusual Outbreaks in India: December 2024 data indicates no substantial increase in respiratory cases in India. Hospitals are well-equipped to handle the usual seasonal surge.
•Preventive Measures:
•Avoid close contact with individuals showing cold or flu symptoms.
•Practice good respiratory hygiene by using separate handkerchiefs or towels for sneezing and coughing.
•Follow general treatment for common colds and fevers.
Monitoring and Global Context
The National Centre for Disease Control (NCDC), under the Union Health Ministry, is actively monitoring respiratory and influenza cases in coordination with international agencies.
The HMPV spread in China has raised concerns globally, with fears of another COVID-like situation. However, Dr. Goyal reassured that India’s health systems are closely observing the situation and are ready to respond if needed.
China’s Response and International Concerns
The outbreak in China has led to heightened scrutiny. Amid international calls for transparency regarding respiratory diseases, including COVID-19, China defended its handling, stating that it has provided significant contributions to global research on disease origins.
